Literature DB >> 9048889

AT selectivity and DNA minor groove binding: modelling, NMR and structural studies of the interactions of propamidine and pentamidine with d(CGCGAATTCGCG)2.

T C Jenkins1, A N Lane.   

Abstract

A molecular modelling strategy has been developed to identify potential binding sites for bis(amidine) ligands in the minor groove of duplex DNA. Calculations of interaction energy for propamidine and pentamidine with d(CGCGAAT TCGCG)2 show that this duplex contains two symmetrically equivalent binding sites of identical affinity, each displaced by 0.3-0.4 bp from the centre of the AT segment. The ligands occupy groove sites spanning approximately 4 and 4-5 bp, respectively with asymmetric binding to the 5'-AATT sequence. The DNA-bis(amidine) interactions have been examined by high-resolution 1H-NMR. The patterns of induced changes in DNA proton chemical shift and the DNA-ligand NOEs confirm that both agents bind in the AT minor groove in a non-centrosymmetric fashion. Detailed structures were determined for each complex using a NOE-restrained simulated annealing procedure, showing that the B-type DNA conformation is not significantly altered upon complexation with either ligand. The free DNA duplex has previously been shown to be extensively hydrated in the minor groove [Kubinec, M.G. and Wemmer, D.E. (1992) J. Am, Chem. Soc. 114, 8739-8740 Liepinsh, E. Otting, G. and Wüthrich, K. (1992) Nucleic Acids Res. 20. 6549-6553]. We detect hydration water close to the A(H2) protons in the presence of propamidine, which may stabilise certain waters against exchange. This conclusion supports recent crystallographic analyses, suggesting that such ligands may use water molecules to bridge between amidinium protons and host DNA bases Details of the ligand interactions with AT-tract DNA duplexes can now be compared for the subsequences 5'-AAT, 5'-AATT and 5'-AAATTT.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048889     DOI: 10.1016/s0167-4781(96)00160-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Reducing levels of toxic RNA with small molecules.

Authors:  Leslie A Coonrod; Masayuki Nakamori; Wenli Wang; Samuel Carrell; Cameron L Hilton; Micah J Bodner; Ruth B Siboni; Aaron G Docter; Michael M Haley; Charles A Thornton; J Andrew Berglund
Journal:  ACS Chem Biol       Date:  2013-09-27       Impact factor: 5.100

2.  Conformational properties and thermodynamics of the RNA duplex r(CGCAAAUUUGCG)2: comparison with the DNA analogue d(CGCAAATTTGCG)2.

Authors:  M R Conte; G L Conn; T Brown; A N Lane
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

3.  Structural and energetic insights into sequence-specific interaction in DNA-drug recognition: development of affinity predictor and analysis of binding selectivity.

Authors:  Jingheng Ning; Weiwei Chen; Jiaojiao Li; Zaixi Peng; Jianhui Wang; Zhong Ni
Journal:  J Mol Model       Date:  2012-12-29       Impact factor: 1.810

4.  Solution studies on DNA interactions of substitution-inert platinum complexes mediated via the phosphate clamp.

Authors:  Y Qu; R G Kipping; N P Farrell
Journal:  Dalton Trans       Date:  2015-02-28       Impact factor: 4.390

5.  Pentamidine inhibits catalytic activity of group I intron Ca.LSU by altering RNA folding.

Authors:  Yi Zhang; Zhijie Li; Daniel S Pilch; Michael J Leibowitz
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

6.  In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.

Authors:  Junichi Mitsuyama; Nobuhiko Nomura; Kyoko Hashimoto; Eio Yamada; Hiroshi Nishikawa; Makoto Kaeriyama; Akiko Kimura; Yozo Todo; Hirokazu Narita
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

7.  Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation.

Authors:  Tao Sun; Yi Zhang
Journal:  Nucleic Acids Res       Date:  2008-02-07       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.